They employed virus mediated HER2 transduction in negative HER2 expressing breast cancer cells, with which they concluded that NIR-tPDT resulted in effectively and selectively killing of the HER2-transducted cells in vitro. The gene discussed is ERBB2; the disease is breast cancer.